Siemens Healthineers (OTCMKTS:SMMNY)‘s stock had its “outperform” rating restated by investment analysts at Credit Suisse Group in a research report issued to clients and investors on Tuesday, The Fly reports.
A number of other equities analysts also recently issued reports on the company. Deutsche Bank Aktiengesellschaft raised Siemens Healthineers from a “hold” rating to a “buy” rating in a research note on Tuesday. Stifel Nicolaus upgraded shares of Siemens Healthineers from a “hold” rating to a “buy” rating in a report on Wednesday, January 6th. Berenberg Bank restated a “buy” rating on shares of Siemens Healthineers in a research report on Thursday, April 29th. Barclays reaffirmed an “equal weight” rating on shares of Siemens Healthineers in a research note on Friday. Finally, HSBC upgraded Siemens Healthineers from a “hold” rating to a “buy” rating in a research report on Tuesday, March 16th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and ten have given a buy rating to the stock. The stock presently has an average rating of “Buy”.
Shares of SMMNY stock traded up $0.65 during midday trading on Tuesday, hitting $29.24. The company had a trading volume of 38,101 shares, compared to its average volume of 51,302. The company’s 50 day simple moving average is $28.05 and its 200 day simple moving average is $26.17. Siemens Healthineers has a 52-week low of $21.03 and a 52-week high of $30.90.
Siemens Healthineers Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems.
Featured Story: Leveraged Buyout (LBO) Explained
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.